Post-MI HF therapy(Tenaya Therapeutics)

N/A

Report date: 2026/03/11 20:02:12

Base Information

Drug NamePost-MI HF therapy(Tenaya Therapeutics)
Drug Alias NamePost-myocardial infarction heart failure therapy(Tenaya Therapeutics Inc)
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTenaya Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesTenaya Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsHeart Failure
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A